Prognostic value of the metabolic syndrome in essential hypertension.

[1]  S. Priori,et al.  2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2004, Heart Drug.

[2]  A. Fontbonne,et al.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up , 1991, Diabetologia.

[3]  P. Ducimetiere,et al.  Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population , 1980, Diabetologia.

[4]  StevenHaffner,et al.  Epidemic Obesity and the Metabolic Syndrome , 2003 .

[5]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[6]  Amir Lerman,et al.  Coronary Endothelial Dysfunction Is Associated With an Increased Risk of Cerebrovascular Events , 2003, Circulation.

[7]  D. Berman,et al.  The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. , 2003, Journal of the American College of Cardiology.

[8]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[9]  Robert Clarke,et al.  Age-specific relevance of usual blood pressure to vascular mortality , 2003, The Lancet.

[10]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[11]  Nancy R Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[12]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[13]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[14]  S. Haffner,et al.  Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. , 2002, Obesity research.

[15]  J. Buring,et al.  Abdominal and total adiposity and risk of coronary heart disease in men , 2001, International Journal of Obesity.

[16]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[17]  F. Perticone,et al.  Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients , 2001, Circulation.

[18]  G. Reboldi,et al.  High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. , 2001, Archives of internal medicine.

[19]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[20]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[21]  M. Laakso,et al.  Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes , 2000, Diabetologia.

[22]  M. Laakso,et al.  Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  E. Sandoya,et al.  Ambulatory Blood Pressure , 1999 .

[24]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[25]  C. Packard,et al.  Associations of indices of adiposity with atherogenic lipoprotein subfractions , 1998, International Journal of Obesity.

[26]  G. Schillaci,et al.  Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. , 1998, Journal of the American College of Cardiology.

[27]  Y. Hara,et al.  Insulin resistance as an independent risk factor for carotid wall thickening. , 1996, Hypertension.

[28]  G. Schillaci,et al.  Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension , 1996, Journal of hypertension.

[29]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[30]  G. Dagenais,et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. , 1996, The New England journal of medicine.

[31]  L. Lind,et al.  Prevalence of insulin resistance in essential hypertension , 1995, Journal of hypertension.

[32]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[33]  G. Schillaci,et al.  Improved electrocardiographic diagnosis of left ventricular hypertrophy. , 1994, The American journal of cardiology.

[34]  G. Reaven,et al.  Prevalence of hyperinsulinaemia in patients with high blood pressure , 1992, Journal of internal medicine.

[35]  J. Clarke,et al.  Mortality in patients of the Glasgow Blood Pressure Clinic. , 1986, Journal of hypertension.

[36]  K. Pennert,et al.  Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. , 1985, Journal of hypertension.

[37]  W. Castelli,et al.  Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.

[38]  K. Pyörälä.  Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland , 1979, Diabetes Care.

[39]  T. Welborn,et al.  Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations , 1979, Diabetes Care.

[40]  J. Stamler,et al.  Epidemiology of coronary heart disease. , 1973, The Medical clinics of North America.